Repeated successful use of eltrombopag in chronic primary immune thrombocytopenia: description of an intriguing case.
Clin Case Rep
; 5(8): 1385-1388, 2017 08.
Article
in En
| MEDLINE
| ID: mdl-28781864
Thrombopoietin receptor agonists (TPO-RAs) are used as effective alternative treatments in ITP patients unresponsive to first-/second-line therapies. TPO-RAs can also be used to normalize platelet count to safely perform invasive procedures and chemotherapy, in case of malignancies. In few responsive patients, TPO-RAs can be suspended maintaining a sustained response.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Clin Case Rep
Year:
2017
Document type:
Article
Country of publication: